Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report
- Collection:
-
Health Policy and Services Research
- Contributor(s):
-
Institute for Clinical and Economic Review, issuing body.
California Technology Assessment Forum, issuing body.
- Publication:
-
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018
- Language(s):
-
English
- Format:
-
Text
- Subject(s):
-
Immunotherapy, Adoptive
Leukemia, B-Cell -- drug therapy
Lymphoma, B-Cell -- drug therapy
Lymphoma, Non-Hodgkin -- drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
Adult
Child
Clinical Trials as Topic
Clofarabine -- therapeutic use
Cost-Benefit Analysis
Immunotherapy, Adoptive -- adverse effects
Immunotherapy, Adoptive -- economics
Receptors, Chimeric Antigen -- therapeutic use
Treatment Outcome
Humans
United States
- Genre(s):
-
Technical Report
- Copyright:
-
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
-
1 online resource (1 PDF file (various pagings))
- Illustrations:
-
Illustrations
- NLM Unique ID:
-
101744954 (See catalog record)
- Permanent Link:
-
http://resource.nlm.nih.gov/101744954
